German specialty chemicals company Evonik has invested in Singapore start-up Revivo BioSystems, which provides an alternative to animal testing.
The investment -- which is Evonik’s first direct investment in the city-state -- will support the development and commercialisation of a technology that uses a realistic 4D model of human skin for the testing of chemical, cosmetic and pharmaceutical compounds.
Revivo BioSystems’s organ-on-a-chip system simulates the interaction of human skin with the substance being tested.
For more insights on corporate trends...
Sign In or Create an account to access our premium content.
Subscription Entitlements:
Less than $9 per month
Unlimited access to latest and premium articles
3 Simultaneous logins across all devices
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)
